Cellnex (CLNX SM) Spain
Report by Insight Investment Research
Robert Crimes views CLNX’s sharp de-rating since 2022 as highly unjustified. Prop. EBITDaL has grown 36%, from €1.8bn in 2022 to €2.4bn in 2025E, yet the share price has declined 26%, massively underperforming the Eurofirst 300. The stock trades on 2025E EV/EBITDaL of 16.7x, a 29% discount to the 22.9x average of its recent disposals. Robert believes CLNX could attract a buyout from a large consortium, such as American Tower, as it offers a non-replicable pan-European network, ranking first or second in eight of the ten countries it operates in. His TP of €69, implies ~135% upside, with CLNX ranking 3rd of 23 on Insight’s Stock Ranking System.